Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Pricing
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
124
open positions at argenx
View Full Profile
Filters:
Immunology ×
Field Clinical Educator, Southeast
argenx
Posted 1mo ago
Atlanta; Marieta; Peachtree City
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Rheumatology Territory Business Manager, Trenton, NJ
argenx
Posted 1mo ago
Trenton; Philadelphia
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Atlanta, GA
argenx
Posted 1mo ago
Atlanta; Marieta; Columbus
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Charlotte NC
argenx
Posted 1mo ago
Charlotte; Raleigh
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Baltimore, MD
argenx
Posted 1mo ago
Baltimore
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Chicago, IL
argenx
Posted 1mo ago
Chicago
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Boston, MA
argenx
Posted 1mo ago
Boston, MA, USA
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Hartford, CT
argenx
Posted 1mo ago
Hartford; New Haven; Springfield, MA
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Long Beach, CA
argenx
Posted 1mo ago
Los Angeles; Long Beach
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Minneapolis, MN
argenx
Posted 1mo ago
Minneapolis
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Jacksonville, FL
argenx
Posted 1mo ago
Jacksonville; Pensacola
$140K - $193K
Full-time
Biostatistical Director - Stat Disease Leader
argenx
Posted 1mo ago
Gent, Belgium; Boston, MA, USA
Full-time
Senior Medical Writer
argenx
Posted 1mo ago
Remote
$128K - $176K
Full-time
DMS/QMS Business Administrator
argenx
Posted 1mo ago
Gent
Full-time
Digital Technology Product Owner, Medical Affairs
argenx
Posted 1mo ago
Remote
$156K - $215K
Full-time
Quality Compliance Lead
argenx
Posted 1mo ago
Gent, Belgium
Full-time
Associate Director, Regulatory Affairs
argenx
Posted 1mo ago
Remote
$164K - $226K
Full-time
Director, Regulatory Affairs
argenx
Posted 1mo ago
Remote
$212K - $292K
Full-time
Medical Affairs and Evidence Generation Asset Lead –Executive Director
argenx
Posted 1mo ago
Remote
Full-time
Head of Commercial Analytics & Insights
argenx
Posted 2mo ago
Remote
$236K - $325K
Full-time
Previous
1
2
3
Company Overview
Active Jobs
171
Pipeline Programs
88
Drug Products
2
Clinical Trials
91
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Writing
Immunology
Senior
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Legal
Immunology
Senior
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Affairs
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Commercial
Immunology
Executive
H-1B · 1 FY23
4
5
6
7
Next
Hematology
Rare Diseases